Comparison of cranial osteopathic treatment with placebo treatment in patients with primary headache. A randomized controlled trial.

Comparison of cranial osteopathic treatment with placebo treatment in patients with primary headache. A randomized controlled trial. - Placebo study: Osteopathy in headache

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

DRKS

Registry ID

DRKS00016998

Enrollment

Registered

2019-03-29

Start date

2019-04-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

G43 G44.2

Interventions

Group 1: Intervention group: Cranial osteopathic treatment, 15 minutes Group 2: Control Group: Cranial Placebo Treatment, 15 minutes

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Primary headache: - tension headache - Migraine without aura - idiopathic stabbing headache - Duration: no restriction - VAS: minimum value 3 - Gender: male and female - Minimum age: 18 years - Maximum age: 65 years - Duration: no restriction - Treatment-patient relationship: first contact - HIT-6 questionnaire score> 45

Exclusion criteria

Exclusion criteria: all forms of secondary headache - Primary headache: - Trigemino-autonomic headache - cluster headache - neurological, psychiatric and medical disorders - acute inflammation - Coronary heart disease - skull and facial fracture - trigeminal - drug-induced headache - chronic immunological diseases - malignant tumor disease - Acute symptoms, such as influenza, cold - Traumatic brain injury - pregnancy

Design outcomes

Primary

Measure	Time frame
Measurement parameters Placebo recognition: questionnaire	—

Secondary

Measure	Time frame
Measurements Effectiveness of Osteopathy in Pre-Post Vergeleich: heartrate-variability, pressure gauges and visuel-analog-scale	—

Countries

Germany

Contacts

Public ContactTanja Gimberlein

Heilpraktikerin

tanja_gimberlein@web.de0151-16527821

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026